To evaluate the impact of the combined IHC score grouping of SLC7A11 and GPAT4 on the prognosis of ovarian cancer patients, we categorized the tissues that tested positive for both SLC7A11 and GPAT4 as the copositive group (n = 21). This evidence concerns the gene SLC7A11 and ovarian cancer.